Stage Celltech Developer Dedicated News Today

NASDAQ Biotech AVCO makes Big Moves Filing 16 Patent Applications, Co-Inventors are leading Universities & Cellular Therapy Developers; Avalon Globocare $AVCO

AVCO’s Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients

AVCO’s Chairman Converts $3.0 million of debt into common stock at $1.25 per share showing continued confidence and support of the business.

This new approach is advancing our capabilities in designing novel immuno-oncology and cellular